Protuoso is a California-based biotech startup developing multifunctional biologics using a platform called MUXBODIES. The company aims to create therapies that target multiple disease pathways simultaneously, addressing limitations of traditional single-pathway drugs.

Total raised
$9.5M
tracked to date
Latest round
Seed
May 27, 2026
Known investors
4
led by Taya Venture

Is this your company?

Claim this profile to get matched with investors who fund Health startups in United States.

Claim this profile →

🏆 Featured in Datapile’s Q2 2026 USA Funding Report

Read the Q2 2026 USA report →
Add this badge to your site
<a href="https://datapile.co/reports/q2-2026-usa-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q2 2026 USA Funding Report</a>

Funding history

  1. 1
    $9.5MSeedMay 27, 2026

    Led by Taya Venture

    Announcement ↗

Founder

Willie Xiang
Willie Xiang
Co-founder

Investors in Protuoso

Backers from this company's tracked funding rounds.

  • TTaya VentureLead investorVC firm
  • DDarwin VenturesVC firm
  • NNSG VenturesVC firm
  • SSEEDSVC firm

Protuoso in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile